Neuroimaging and CBD for Opiod Use Disorder
Latest Information Update: 28 Sep 2023
At a glance
- Drugs Cannabidiol (Primary)
- Indications Opioid-related disorders
- Focus Pharmacodynamics
- 30 Jun 2023 Planned primary completion date changed from 12 Nov 2024 to 12 Nov 2025.
- 01 May 2023 Status changed from active, no longer recruiting to recruiting.
- 01 May 2023 Planned number of patients changed from 200 to 160.